Figure 3From: Seven years of use of implantable cardioverter-defibrillator therapies: a nationwide population-based assessment of their effectiveness in real clinical settingsOverall survival by underlying cardiac disease (ICD-alone group). Kaplan-Meier survival estimates were not significantly different between groups (Peto’s test p = 0.05). These survival curves with underlying disease information drawn only from the hospital admission (AIH) forms.Back to article page